DocuSign (NASDAQ:DOCU - Get Free Report) announced its earnings results on Thursday. The company reported $0.86 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.02, Briefing.com reports. The business had revenue of $776.25 million for the quarter, compared to analyst estimates of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company's quarterly revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.76 EPS. DocuSign updated its FY 2026 guidance to EPS and its Q1 2026 guidance to EPS.
DocuSign Stock Performance
Shares of DOCU traded up $11.06 on Friday, reaching $85.76. The stock had a trading volume of 11,927,431 shares, compared to its average volume of 2,402,407. The firm has a market capitalization of $17.33 billion, a price-to-earnings ratio of 17.68, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. The company has a 50-day simple moving average of $87.97 and a 200-day simple moving average of $79.37. DocuSign has a 12-month low of $48.70 and a 12-month high of $107.86.
Analysts Set New Price Targets
Several equities analysts have recently commented on the company. Robert W. Baird increased their price objective on DocuSign from $59.00 to $100.00 and gave the company a "neutral" rating in a research report on Friday, December 6th. Morgan Stanley increased their price objective on DocuSign from $62.00 to $97.00 and gave the company an "equal weight" rating in a research report on Friday, December 6th. Hsbc Global Res upgraded DocuSign to a "moderate sell" rating in a research report on Friday, December 6th. Bank of America reduced their price objective on DocuSign from $112.00 to $98.00 and set a "neutral" rating on the stock in a research report on Friday. Finally, JPMorgan Chase & Co. upgraded DocuSign from an "underweight" rating to a "neutral" rating and increased their price objective for the company from $70.00 to $75.00 in a research report on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $95.58.
Get Our Latest Report on DOCU
Insider Activity
In other DocuSign news, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction on Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares in the company, valued at approximately $13,712,088.78. The trade was a 6.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 15,588 shares of DocuSign stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total value of $1,524,194.64. Following the transaction, the chief financial officer now owns 85,851 shares of the company's stock, valued at $8,394,510.78. The trade was a 15.37 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 104,422 shares of company stock worth $9,665,394 in the last quarter. 1.66% of the stock is owned by company insiders.
DocuSign Company Profile
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
